SNRPB and neoplasm: In addition, platelet (p = 0.015), serum AFP (p = 0.003), PIVKA II (p = 0.002), presence of microvascular invasion (MVI; p < 0.001), advanced tumor stage (mUICC stage III-IV, p < 0.001), SNRPB expression (p = 0.008), CETN2 expression (p = 0.008), HMGA1 expression (p = 0.001), and RACGAP1 expression (p < 0.001) were significantly associated with DFS (Table 1).